|
sodium channel blocker
An agent that inhibits sodium influx through cell membranes.
|
|
|
anti-arrhythmia drug
A drug used for the treatment or prevention of cardiac arrhythmias. Anti-arrhythmia drugs may affect the polarisation-repolarisation phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibres.
local anaesthetic
Any member of a group of drugs that reversibly inhibit the propagation of signals along nerves. Wide variations in potency, stability, toxicity, water-solubility and duration of action determine the route used for administration, e.g. topical, intravenous, epidural or spinal block.
|
|
|
N-(2,6-dimethylphenyl)alaninamide
|
|
2-Amino-2',6'-propionoxylidide
|
ChemIDplus
|
|
2-amino-N-(2,6-dimethylphenyl)propanamide
|
ChEBI
|
2-Amino-N-(2,6-dimethylphenyl)propionamid
|
ChemIDplus
|
|
Alanyl-2,6-xylidide
|
ChemIDplus
|
|
2416564
|
Beilstein Registry Number
|
Beilstein
|
|
2416564
|
Reaxys Registry Number
|
Reaxys
|
|
41708-72-9
|
CAS Registry Number
|
ChemIDplus
|
